PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

An immunosuppressive drug could delay the onset of neurodegenerative diseases

Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of diseases such as Alzheimer's or Parkinson's

2012-10-15
(Press-News.org) Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's. This is the main conclusion of a study published in the Nature in which has collaborated the researcher Isidro Ferrer, head of the group of Neuropathology at the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital and Full Professor of Pathological Anatomy at the University of Barcelona. The research was led by researchers from the International School for Advanced Studies (SISSA) in Trieste (Italy).

The collaboration of the research group led by Dr. Ferrer with SISSA researchers began five years ago when they observed that Parkinson's patients showed a deficit in UCHL1 protein. At that time, researchers didn't know what mechanism produced this deficit. To discover it a European project was launched. It was coordinated by the Italian researchers and participated by other European research groups, including the group led by Dr. Ferrer. The project, called Dopaminet, focused on how dopaminergic neurons (brain cells whose neurotransmitter is dopamine) are involved in Parkinson's disease.

Contrary to most common hypothesis that a DNA fragment encodes a protein through a messenger RNA molecule, the researchers found that it also works in reverse. They found a balance between the protein and its mirror protein, which is configured in reverse, and they are mutually controlled. If the protein mirror is located in the nucleus of the cell, it does not interact with the protein, while if it is in the cytoplasm, then both of them interact.

In the case of Parkinson's disease the protein UCHL1 appears reduced and also its mirror protein is localized in the nucleus, and in the cytoplasm. Thus, the researchers sought a method to extract the mirror protein from the nucleus and made it interact with the original UCHL1 protein. The authors found that rapamycin was able to extract them from the nucleus. The drug allows the two proteins, the UCHL1 and its mirror, hold together in the cytoplasm, which would correct the mistakes that occur in Parkinson's disease.

This in vitro research has allowed describing a new unknown mechanism. It is necessary that the UCHL1 mirror protein should accumulate in the nucleus and escape from the cytoplasm and join the UCLH1 protein. The combination of both makes the system work.

"The rapamycin can not cure Parkinson's disease, but it may delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's itself. Rapamycin can protect and delay the beginning of these diseases. It can complete the treatment, but it should be combined with other existing treatments", explains Isidro Ferrer.

Anyway, it is still far its application in patients. The next step is to validate these results in animal models and study the effects of rapamycin in combination with other drugs.

### About Us

The Bellvitge Biomedical Research Institute (IDIBELL) is a research center created in 2004 and it is participated by the Bellvitge University Hospital, the Catalan Institute of Health, the Catalan Institute of Oncology, and the University of Barcelona. IDIBELL is located at Biopol'H at L'Hospitalet de Llobregat and is member of the Health Universtitat de Barcelona Campus.

Article reference

Claudia Carrieri, Laura Cimatti, Marta Biagioli, Anne Beugnet, Silvia Zucchelli, Stefania Fedele, Elisa Pesce,Isidre Ferrer, Licio Collavin, Claudio Santoro, Alistair R. R. Forrest, Piero Carninci, Stefano Biffo, Elia Stupka & Stefano Gustincich. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature. DOI: 10.1038/nature11508


ELSE PRESS RELEASES FROM THIS DATE:

Bicycle helmets prevent fatal head injuries

2012-10-15
Cyclists who died of a head injury were three times as likely to not be wearing a helmet compared with those who died of other injuries, according to a study in CMAJ (Canadian Medical Association Journal). "We saw an association between dying as a result of sustaining head injury and not wearing a helmet," states Dr. Navindra Persaud, Keenan Research Centre and the Department of Family and Community Medicine, St. Michael's Hospital, Toronto, with coauthors. "These results are consistent with a protective effect of helmets on cycling deaths." There is scant evidence ...

'Mother's kiss' safe and effective for removing foreign objects from children's noses

2012-10-15
A technique called the "mother's kiss" for removing foreign objects from the nasal passages of young children appears to be a safe and effective approach, found a study published in CMAJ (Canadian Medical Association Journal). "The mother's kiss appears to be a safe and effective technique for first-line treatment in the removal of a foreign body from the nasal cavity," writes Dr. Stephanie Cook, Buxted Medical Centre, Buxted, United Kingdom, with coauthors. "In addition, it may prevent the need for general anesthesia in some cases." The technique, known since the ...

Scratching the surface of psoriasis

2012-10-15
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate. In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. These results indicate that IL-36 ...

JCI early table of contents for Oct. 15, 2012

2012-10-15
Scratching the surface of psoriasis Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate. In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. ...

Mice at risk of asthma, allergies can fight off skin cancer

2012-10-15
A molecule involved in asthma and allergies has now been shown to make mice resistant to skin cancer, according to scientists at Washington University School of Medicine in St. Louis. The molecule, called TSLP (thymic stromal lymphopoietin), is produced by damaged skin and activates the immune system. Chronic low levels of TSLP are suspected in making the immune system oversensitive to what should be a harmless environment, leading to the skin rashes and overproduction of mucus common in allergies and asthma. "But at extremely high levels, TSLP appears to train the ...

New approaches in the treatment of alcohol dependence

2012-10-15
"Addiction is a brain disease" was the title of an editorial in the renowned journal "Science" 15 years ago. The author argued that recognising addiction as a disorder of the brain can impact society´s overall health and social policy strategies and help diminish the health and social costs associated with drug abuse and addiction (Leshner, 1997). Such a presentation of the complex concept of addiction was revolutionary, as social and psychological aspects were largely considered as the most important, although not the only ones involved. Some years later, clinicians ...

Study sheds light on role of exercise and androgens such as testosterone on nerve damage repair

2012-10-15
A study by researchers from Emory University and Indiana University found that the beneficial effects daily exercise can have on the regeneration of nerves also require androgens such as testosterone in both males and females. It is the first report of both androgen-dependence of exercise on nerve regeneration and of an androgenic effect of exercise in females. "The findings will provide a basis for the development of future treatment strategies for patients suffering peripheral nerve injuries," said Dale Sengelaub, professor in the Department of Psychological and Brain ...

University of Tennessee study confirms solar wind as source for moon water

University of Tennessee study confirms solar wind as source for moon water
2012-10-15
Three years ago University of Tennessee, Knoxville, researchers helped to discover water on the surface of the moon. Now, they are piecing together the origin of that water: solar wind. A new study confirms solar wind as a source for water embedded in the lunar surface. Solar wind is the continuous flow of charged particles from the sun. Scientists have speculated it to be responsible for water on the surface of the moon. Last year Larry Taylor, distinguished professor in the Department of Earth and Planetary Sciences, confirmed comets as the source for water ...

LA BioMed's Dr. Virender Rehan studies maternal nicotine's effects on unborn children and asthma

2012-10-15
LOS ANGELES (Oct. 15, 2012) – Currently, there are approximately 25 million people in the United States who suffer from the lifelong effects of asthma – wheezing, breathlessness, tightness in the chest, coughing – and the numbers are rising each year. According to the Centers for Disease Control and Prevention (CDC), the number of people in the United States diagnosed with asthma grew by 4.3 million from 2001 to 2009. Approximately 1 in 10 children and 1 in 12 adults suffer from asthma; the numbers are even higher among racial/ethnic groups, with 1 in 6 children in the ...

Urgent need for tuberculosis vaccines; experts report progress, obstacles in growing drug resistance

2012-10-15
Contact: Coimbra Sirica csirica@burnesscommunications.com 44-743-538-4915 Burness Communications Annmarie Leadman aleadman@aeras.org 301-332-8252 Aeras Urgent need for tuberculosis vaccines; experts report progress, obstacles in growing drug resistance As World Health Organization prepares to release report on global TB incidence, researchers say UK at forefront of efforts to develop critical medical tools London (October 15, 2012) – Drawing on recent findings of a significant rise in cases of drug-resistant tuberculosis in the UK and globally, top TB researchers ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] An immunosuppressive drug could delay the onset of neurodegenerative diseases
Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of diseases such as Alzheimer's or Parkinson's